A citation-based method for searching scientific literature

David R Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K Shadoan, Arthur Sands, Brian Zambrowicz, Zhi-Ming Ding. J Pharmacol Exp Ther 2013
Times Cited: 116



Robert L Dobbins, Frank L Greenway, Lihong Chen, Yaping Liu, Sharon L Breed, Susan M Andrews, Jeffrey A Wald, Ann Walker, Chari D Smith. Am J Physiol Gastrointest Liver Physiol 2015
Times Cited: 66




List of shared articles



Times cited

Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice.
Yasushi Honda, Anna Ozaki, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Masato Yoneda,[...]. J Pharmacol Sci 2021
0

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption.
David R Powell, Brian Zambrowicz, Linda Morrow, Carine Beysen, Marcus Hompesch, Scott Turner, Marc Hellerstein, Phillip Banks, Paul Strumph, Pablo Lapuerta. J Clin Endocrinol Metab 2020
12

The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Christoffer Martinussen, Simon Veedfald, Carsten Dirksen, Kirstine N Bojsen-Møller, Maria S Svane, Nicolai J Wewer Albrechtsen, Gerrit van Hall, Viggo B Kristiansen, Mogens Fenger, Jens J Holst,[...]. Am J Physiol Endocrinol Metab 2020
6

Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation.
Cong Xie, Karen L Jones, Christopher K Rayner, Tongzhi Wu. Pharmaceutics 2020
5

Fucoidan from Ascophyllum nodosum Suppresses Postprandial Hyperglycemia by Inhibiting Na+/Glucose Cotransporter 1 Activity.
Xindi Shan, Xueliang Wang, Hao Jiang, Chao Cai, Jiejie Hao, Guangli Yu. Mar Drugs 2020
1

A Modified Tripeptide Motif of RS1 (RSC1A1) Down-Regulates Exocytotic Pathways of Human Na+-d-glucose Cotransporters SGLT1, SGLT2, and Glucose Sensor SGLT3 in the Presence of Glucose.
Nadine Schäfer, Prashanth Reddy Rikkala, Maike Veyhl-Wichmann, Thorsten Keller, Christian Ferdinand Jurowich, Dietmar Geiger, Hermann Koepsell. Mol Pharmacol 2019
2

Arbutus unedo L., (Ericaceae) inhibits intestinal glucose absorption and improves glucose tolerance in rodents.
Hanae Naceiri Mrabti, Moulay El Abbes Faouzi, François Massako Mayuk, Hanane Makrane, Nicolas Limas-Nzouzi, Siegfried Didier Dibong, Yahia Cherrah, Ferdinand Kouoh Elombo, Bernard Gressier, Jehan-François Desjeux,[...]. J Ethnopharmacol 2019
4

SGL5213, a novel and potent intestinal SGLT1 inhibitor, suppresses intestinal glucose absorption and enhances plasma GLP-1 and GLP-2 secretion in rats.
Fusayo Io, Emi Gunji, Hiroko Koretsune, Koji Kato, Mami Sugisaki-Kitano, Lisa Okumura-Kitajima, Kayo Kimura, Saeko Uchida, Koji Yamamoto. Eur J Pharmacol 2019
3

What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.
Jessica A Dominguez Rieg, Timo Rieg. Diabetes Obes Metab 2019
20

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.
Daniël H van Raalte, Petter Bjornstad, Frederik Persson, David R Powell, Rita de Cassia Castro, Ping Stella Wang, Minzhi Liu, Hiddo J L Heerspink, David Cherney. Diabetes Care 2019
13

Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents.
Fuyong Du, Simon A Hinke, Cassandre Cavanaugh, David Polidori, Nathanial Wallace, Thomas Kirchner, Matthew Jennis, Wensheng Lang, Gee-Hong Kuo, Micheal D Gaul,[...]. J Pharmacol Exp Ther 2018
8

Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care.
Thomas Danne, Torben Biester, Olga Kordonouri. Diabetes Technol Ther 2018
19

Development of SGLT1 and SGLT2 inhibitors.
Timo Rieg, Volker Vallon. Diabetologia 2018
81

Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk.
Sara B Seidelmann, Elena Feofanova, Bing Yu, Nora Franceschini, Brian Claggett, Mikko Kuokkanen, Hannu Puolijoki, Tapani Ebeling, Markus Perola, Veikko Salomaa,[...]. J Am Coll Cardiol 2018
22


LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice.
David R Powell, Melinda G Smith, Deon D Doree, Angela L Harris, Jennifer Greer, Christopher M DaCosta, Andrea Thompson, Sabrina Jeter-Jones, Wendy Xiong, Kenneth G Carson,[...]. J Pharmacol Exp Ther 2017
15

Targeting gastrointestinal nutrient sensing mechanisms to treat obesity.
Mariana Norton, Kevin G Murphy. Curr Opin Pharmacol 2017
12

Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.
Panai Song, Akira Onishi, Hermann Koepsell, Volker Vallon. Expert Opin Ther Targets 2016
72

Intestinal SGLT1 in metabolic health and disease.
Anders Lehmann, Pamela J Hornby. Am J Physiol Gastrointest Liver Physiol 2016
29